ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 173046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 173046; 2) Community: the network communities that were significantly associated with the response to NSC 173046; 3) Molecule: the relationships between components within communities and NSC 173046; 4) MDR: the compounds that were significantly associated with the NSC 173046.

NSC Compound Enrichment Correlation
NSC 638034 Null 0.0370731367697097 -0.12448795
NSC 648365 Insulin-Methotrexate conjugate 0.0370731367697097 0.12390784
NSC 649677 Null 0.0370731367697097 -0.041826668
NSC 657751 Null 0.0370731367697097 0.21694493
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0370731367697097 0.077139269
NSC 662253 Null 0.0370731367697097 0.066958855
NSC 666767 Null 0.0370731367697097 0.25224086
NSC 668337 Null 0.0370731367697097 -0.053826987
NSC 676676 ARQ monoacetate 0.0370731367697097 0.095633601
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.0370731367697097 0.076699379
Total:91  Current:68    [First] [Prev] [Next] [Last]